查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1967587

精子計數檢測市場－全球產業規模、佔有率、趨勢、機會、預測：按技術、最終用戶、地區和競爭對手分類，2021-2031年

Sperm Count Test Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technique, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球精子計數檢測市場預計將從 2025 年的 31.3 億美元成長到 2031 年的 47.1 億美元，複合年成長率為 7.05%。

該市場涵蓋用於評估精子濃度和品質的診斷工具，這些工具既可用於臨床，也可用於家庭環境。推動這一市場成長的主要因素是男性不孕症盛行率的上升以及全球精子數量的下降，這使得便捷且頻繁的篩檢方法變得尤為重要。根據美國泌尿系統協會和生殖醫學會2024年的數據，男性因素導致的不孕症在高達60%的夫婦中造成。如此高的盛行率，加上人們對生殖健康意識的不斷提高，持續推動對精準診斷方法的需求。

市場概覽
預測期 2027-2031
市場規模：2025年 31.3億美元
市場規模：2031年 47.1億美元
複合年成長率：2026-2031年 7.05%
成長最快的細分市場 基於智慧型手機
最大的市場 北美洲

儘管臨床需求明確，但由於先進的不孕症檢測費用高昂，且許多地區缺乏全面的醫療保險，市場擴張面臨許多障礙。這種經濟負擔往往限制了患者獲得必要的診斷服務，尤其是在開發中國家。因此，儘管需求旺盛，經濟障礙仍使許多人無法獲得這些必要的醫療資源，阻礙了精子計數解決方案的廣泛應用。

市場促進因素

男性不孕率上升和精子品質下降是全球精子計數檢測市場的主要促進因素。隨著生活方式的改變和環境壓力對生殖健康的影響日益加劇，對準確、頻繁的精液分析的需求也隨之成長。精子參數的驚人變化趨勢凸顯了這個生物學危機。根據Igyxos Biotherapeutics公司2024年6月發布的報告，自2020年以來，全球精子數量每年下降超過2.6%，較過去幾十年1.2%的年降幅有所加快。此外，根據Ferring Pharmaceuticals公司2024年發布的報告，全球約有六分之一的男性患有不孕症，這意味著龐大的患者群體需要可靠的診斷評估。

同時，由於對私人家用不孕症檢測套組的需求激增，市場格局正在重塑。越來越多的男性選擇提供匿名性和便利性的直接面對消費者的解決方案，從而避免前往傳統的臨床機構。這項轉變的驅動力在於男性不孕症社會污名的消除以及基於智慧型手機的分析技術的普及。主要產業參與者的成長也印證了這些工具的快速普及。例如，Legacy Inc.在2024年7月報告稱，該公司已分析了超過25,000份精液樣本，並獲得了750萬美元的新資金籌措。居家檢體採集方式的興起正在推動市場多元化，使服務能夠惠及尚未接受治療的人群，並催生出一個全新的主動式生殖健康管理領域。

市場挑戰

不孕症診斷費用高昂且缺乏全面的保險報銷是全球精子計數檢測市場成長的主要障礙。雖然基礎篩檢看似唾手可得，但這通常只是昂貴醫療流程中的一步，許多患者仍然難以負擔。在生殖醫學醫療保險覆蓋範圍有限或缺乏的地區，經濟負擔完全落在病人身上。這種經濟壓力構成了市場准入壁壘，導致患者推遲或放棄必要的診斷程序，並阻礙了開發中國家和低收入者的市場滲透。

近期行業數據也印證了這一經濟障礙的嚴重性。根據美國生殖醫學會統計，2024年一個週期的生育治療平均費用在12,000美元至15,000美元之間。如此高的費用令患者猶豫不決，甚至不敢開始診斷流程，因為他們擔心治療費用會失控。因此，精子計數檢測的需求被人為抑制，經濟壓力迫使許多夫婦徹底放棄生殖健康服務。

市場趨勢

人工智慧 (AI) 和機器學習 (ML) 的融合正在從根本上改變全球精子計數檢測市場，將精液分析從主觀的人工評估轉變為高度精確的自動化診斷。這些演算法的進步使得攜帶式設備能夠達到臨床等級的精準度，從而可以快速評估精子形態和活力，避免人工觀察帶來的誤差。 2024 年 8 月，莫納什大學的研究人員開發出一種人工智慧驅動的模型，能夠在幾秒鐘內分析活體精子樣本，準確率高達 93%（根據 Knightley 報道），這項技術飛躍尤為引人注目。透過自動化複雜的診斷標準，這些創新正在使檢測結果標準化，並提高家庭和臨床環境中的數據可靠性。

同時，市場正日益融合遠距遠端醫療服務，精子計數檢測也從一項獨立的診斷產品演變為通往綜合遠距生育治療的門戶。這一趨勢彌合了初步篩檢和醫療干預之間的鴻溝，數位平台可在檢測完成後立即將使用者與生殖泌尿系統無縫連接。這種整合式醫療模式對於涵蓋未接受治療的人至關重要。根據Posterity Health於2024年6月發布的報告顯示，美國有超過300萬男性患有睪固酮缺乏症，但由於就醫障礙，僅有32%的人接受了專業治療。透過將診斷功能整合到虛擬醫療生態系統中，企業正在消除這些障礙，並確保異常檢測結果能夠立即轉化為可執行的醫療方案。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球精子計數檢測市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依技術（顯微鏡、層析法免疫檢測和比色反應、基於智慧型手機的方法、其他方法）
    • 依最終使用者（醫院、不孕症治療中心等）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美精子數檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲精子計數檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區精子計數檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲精子計數檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美精子計數檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球精子計數檢測市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • DNA Diagnostics Center, Inc.
  • BioMerieux SA
  • Medical Electronic Systems
  • Thermo Fisher Scientific Inc.
  • CooperSurgical, Inc.
  • Vitrolife Sweden AB
  • Hamilton Thorne Inc.
  • Artron Laboratories Inc.
  • Fertility Focus Ltd.
  • MICROPTIC SL

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 24332

The Global Sperm Count Test Market is projected to expand from USD 3.13 Billion in 2025 to USD 4.71 Billion by 2031, registering a CAGR of 7.05%. This market encompasses diagnostic tools designed to assess sperm concentration and quality within both clinical and home-based environments. The primary driver of this growth is the increasing prevalence of male infertility and a global decline in sperm counts, which necessitates accessible and frequent screening methods. Data from the American Urological Association and the American Society for Reproductive Medicine in 2024 indicates that male factor infertility contributes to conception difficulties in up to 60 percent of couples. This high prevalence, alongside growing awareness of reproductive health, sustains the demand for accurate diagnostic modalities.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.13 Billion
Market Size 2031USD 4.71 Billion
CAGR 2026-20317.05%
Fastest Growing SegmentSmartphone-based
Largest MarketNorth America

Despite the clear clinical need, market expansion faces significant hurdles due to the prohibitive costs of advanced fertility testing and the lack of comprehensive insurance coverage in many regions. This financial strain often limits patient access to essential diagnostic services, particularly in developing economies. Consequently, the broader adoption of sperm count testing solutions is impeded, as economic barriers prevent many individuals from utilizing these necessary healthcare resources despite the evident demand.

Market Driver

The escalating rates of male infertility and declining sperm quality serve as the primary engines propelling the Global Sperm Count Test Market. As lifestyle changes and environmental stressors increasingly impact reproductive health, the urgency for precise and frequent semen analysis has intensified. This biological crisis is highlighted by alarming trends in sperm parameters; according to Igyxos Biotherapeutics in June 2024, global sperm counts have fallen by over 2.6 percent annually since 2020, accelerating from the 1.2 percent annual decrease seen in prior decades. Furthermore, Ferring Pharmaceuticals reported in 2024 that infertility affects approximately one in six people worldwide, creating a substantial patient pool that requires reliable diagnostic evaluation.

Simultaneously, the market is being reshaped by a surging demand for private, at-home fertility testing kits. Men are increasingly opting for direct-to-consumer solutions that offer anonymity and convenience, bypassing traditional clinical settings. This shift is supported by the destigmatization of male infertility and the integration of smartphone-based analysis technologies. The rapid adoption of these tools is evident in the growth of key industry players; for instance, Legacy reported in July 2024 that it has analyzed over 25,000 sperm samples and secured $7.5 million in new financing. This preference for home-based collection is decentralizing the market, allowing providers to reach untreated populations and fostering a new segment of proactive reproductive health management.

Market Challenge

The high cost of fertility diagnostics and the lack of comprehensive insurance reimbursement constitute major obstacles to the growth of the Global Sperm Count Test Market. While basic screenings may seem accessible, they are often merely the first step in a broader, expensive medical journey that remains unaffordable for many patients. In regions where healthcare coverage for reproductive issues is limited or non-existent, the financial burden falls entirely on the patient. This economic pressure creates a significant barrier to entry, causing individuals to delay or forego essential diagnostic procedures and hampering market penetration in developing economies and lower-income demographics.

The severity of this financial deterrent is underscored by recent industry data. According to the American Society for Reproductive Medicine, the average cost for a single cycle of fertility treatment in 2024 ranged between $12,000 and $15,000. This substantial expense often discourages patients from even initiating the diagnostic process due to fears of cascading treatment costs. Consequently, the demand for sperm count tests is artificially suppressed, as economic constraints force many couples to opt out of the reproductive healthcare system entirely.

Market Trends

The integration of Artificial Intelligence (AI) and Machine Learning (ML) is fundamentally transforming the Global Sperm Count Test Market by shifting semen analysis from subjective manual evaluation to high-precision automated diagnostics. These algorithmic advancements embed clinical-grade accuracy into portable devices, enabling rapid assessment of sperm morphology and motility without the variability associated with human observation. This technological leap was highlighted by The Nightly in August 2024, reporting that researchers at Monash University developed an AI-driven model capable of analyzing live sperm samples with 93 percent accuracy in seconds. By automating complex diagnostic criteria, these innovations standardize results across both home-based and clinical environments, enhancing data reliability.

Concurrently, the market is experiencing a convergence with telehealth services, evolving sperm count testing from a standalone diagnostic product into a gateway for comprehensive remote fertility care. This trend bridges the gap between initial screening and medical intervention, as digital platforms now seamlessly connect users with reproductive urologists immediately following test completion. This integrated care model is vital for capturing untreated populations; according to Posterity Health in June 2024, while over 3 million men in the United States suffer from testosterone deficiency, only 32 percent seek professional treatment due to access barriers. By embedding diagnostics within a virtual health ecosystem, companies are removing these hurdles and ensuring that abnormal results trigger immediate, actionable medical pathways.

Key Market Players

  • DNA Diagnostics Center, Inc.
  • BioMerieux SA
  • Medical Electronic Systems
  • Thermo Fisher Scientific Inc.
  • CooperSurgical, Inc.
  • Vitrolife Sweden AB
  • Hamilton Thorne Inc.
  • Artron Laboratories Inc.
  • Fertility Focus Ltd.
  • MICROPTIC S.L.

Report Scope

In this report, the Global Sperm Count Test Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Sperm Count Test Market, By Technique

  • Microscopy
  • Chromatographic Immunoassay and Colorimetric Reaction
  • Smartphone-based
  • Others

Sperm Count Test Market, By End User

  • Hospitals
  • Fertility Centers
  • Others

Sperm Count Test Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Sperm Count Test Market.

Available Customizations:

Global Sperm Count Test Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Sperm Count Test Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (Microscopy, Chromatographic Immunoassay and Colorimetric Reaction, Smartphone-based, Others)
    • 5.2.2. By End User (Hospitals, Fertility Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Sperm Count Test Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By End User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Sperm Count Test Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technique
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Sperm Count Test Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technique
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Sperm Count Test Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technique
        • 6.3.3.2.2. By End User

7. Europe Sperm Count Test Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By End User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Sperm Count Test Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By End User
    • 7.3.2. France Sperm Count Test Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Sperm Count Test Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Sperm Count Test Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technique
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Sperm Count Test Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technique
        • 7.3.5.2.2. By End User

8. Asia Pacific Sperm Count Test Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By End User
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Sperm Count Test Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By End User
    • 8.3.2. India Sperm Count Test Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Sperm Count Test Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Sperm Count Test Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technique
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Sperm Count Test Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technique
        • 8.3.5.2.2. By End User

9. Middle East & Africa Sperm Count Test Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By End User
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Sperm Count Test Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By End User
    • 9.3.2. UAE Sperm Count Test Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By End User
    • 9.3.3. South Africa Sperm Count Test Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By End User

10. South America Sperm Count Test Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By End User
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Sperm Count Test Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By End User
    • 10.3.2. Colombia Sperm Count Test Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By End User
    • 10.3.3. Argentina Sperm Count Test Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Sperm Count Test Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. DNA Diagnostics Center, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. BioMerieux SA
  • 15.3. Medical Electronic Systems
  • 15.4. Thermo Fisher Scientific Inc.
  • 15.5. CooperSurgical, Inc.
  • 15.6. Vitrolife Sweden AB
  • 15.7. Hamilton Thorne Inc.
  • 15.8. Artron Laboratories Inc.
  • 15.9. Fertility Focus Ltd.
  • 15.10. MICROPTIC S.L.

16. Strategic Recommendations

17. About Us & Disclaimer